摘要
目的探讨过氧化物酶体增殖激活物受体γ(peroxisome proliferators-activated receptorγ,PPARγ)的激活在蛇葡萄素(ampelopsin,AMP)抑制乳腺癌细胞增殖和诱导细胞增殖凋亡中的作用。方法以不同浓度AMP(20、40、60、80μmol/L)分别处理人乳腺癌MDA-MB-231、MCF-7细胞24 h后,荧光素酶报告基因法检测AMP对PPARγ的激活作用,CCK-8检测细胞活力,流式细胞仪检测细胞凋亡,Western blot检测凋亡相关蛋白的表达,Caspase-3活性检测试剂盒检测Caspase-3活性。结果与PPARγ激动剂罗格列酮一样,AMP剂量依赖性地增强报告基因荧光素酶活性,同时显著抑制乳腺癌细胞增殖并诱导细胞凋亡(P<0.05);Western blot检测结果显示,AMP在显著上调乳腺癌细胞凋亡相关蛋白Bax、PTEN、活化Caspase-3表达的同时下调Bcl-2蛋白及Bcl-2/Bax比值;激酶活性检测结果显示,AMP可显著增强Caspase-3激酶活性,以上作用均可被PPARγ特异性拮抗剂GW9662显著削弱。结论AMP可能是PPARγ的天然激动剂,其通过激活PPARγ信号途径抑制乳腺癌细胞增殖并诱导细胞凋亡。
Objective To investigate whether the activation of proliferators-activated receptor γ (PPARγ) is required for ampelopsin (AMP)-induced cell growth inhibition and apoptosis in human breast cancer cells. Methods After different concentrations of AMP (20, 40, 60 and 80 μmol/L) was used to treat breast cancer cell lines MCF-7 and MDA-MB-231 for 24 h respectively, PPAR7 activity was measured by luciferase reporter assay, cell viability was assessed by CCK-8 assay, and cell apoptosis was measured by flow cytometry with Annexin V-FITC/PI staining. Western blotting was used to measure the expression of apoptosis related proteins, and a clorimetric assay kit was employed to detect Caspase-3 activity. Results As PPARγ agonist rosiglitazone, AMP treatment also enhanced the activity of luciferase reporter, inhibited cell viability and induced apoptosis (P 〈 0. 05 ) in MCF-7 and MDA-MB-231 cells in dose-dependent manners. Furthermore, Western blotting showed that AMP significantly up-regulated apoptosis related proteins Bax and PTEN, activated Caspase-3, down-regulated Bcl-2 and decreased the ratio of Bcl-2/Bax. Clorimetric assay indicated that the treatment enhanced the activity of Caspase-3. All above results could be obviously attenuated by PPARγ specific antagonist GW9662. Conclusion AMP maybe a natural agonist of PPARγ, and it can suppress cell proliferation and induce apoptosis in breast cancer cells by activating PPARγ.
作者
周永
郑金英
金小玲
徐小华
冉莉
张乾勇
朱俊东
糜漫天
ZHOU Yong;ZHENG Jinying;JIN Xiaoling;XU Xiaohua;RAN Li;ZHANG Qianyong;ZHU Jundong;MI Mantian(Department of Clinic Nutrition, Banan District People' s Hospital of Chongqing, Chongqing, 401320;Department of Nutrition and Food Safety, Faculty of Military Preventive Medicine, Army Medical University (Third Military Medical University), Chongqing, 400038, China)
出处
《第三军医大学学报》
CAS
CSCD
北大核心
2018年第13期1185-1191,共7页
Journal of Third Military Medical University
基金
重庆市基础科学与前沿技术研究项目(CSTC2017jcyj AX0305)
陆军军医大学电磁辐射医学防护教育部重点实验室开放课题(2017DCKF002)~~